Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese Patients
Phase 4
- Conditions
- Exudative Age-Related Macular Degeneration
- Registration Number
- JPRN-UMIN000027799
- Lead Sponsor
- Akita University Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) previous treatment for AMD 2) polypoidal choroidal vasculopathy 3) retinal angiomatous proliferation 4) diabetic maculopathy, retinal vascular occlusion, or idiopathic macular telangiectasia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The mean changes of best-corrected visual acuity at month 24 compared with baseline
- Secondary Outcome Measures
Name Time Method The prevalence of eyes with only ranibizumab by PRN (pro re nata)